Trials / Not Yet Recruiting
Not Yet RecruitingNCT07532655
A Single Ascending Dose Study of SYH2082 Injection in Healthy Participants
A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Dose of SYH2082 Injection in Healthy Participants
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (estimated)
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and tolerability of single dose of SYH2082 Injection in healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SYH2082 Injection | A subcutaneous injection in the abdomen of the corresponding dose of SYH2082 Injection according to the assigned dose cohort. |
| DRUG | Placebo | A subcutaneous injection in the abdomen of the corresponding dose of Placebo according to the assigned dose cohort. |
Timeline
- Start date
- 2026-04-14
- Primary completion
- 2026-10-28
- Completion
- 2027-02-09
- First posted
- 2026-04-16
- Last updated
- 2026-04-16
Source: ClinicalTrials.gov record NCT07532655. Inclusion in this directory is not an endorsement.